Contrary to our results, a study of breast cancer displayed that DDX21 low expression was correlated with higher metastasis and poor clinical prognosis, and knockdown of DDX21 promoted breast cancer cells epithelial-mesenchymal transition (EMT), invasion and migration in vitro and in vivo [40]. The gene discussed is DDX21; the disease is breast carcinoma.